What is short bowel syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Short Bowel Syndrome Definition

Short bowel syndrome (SBS) is a devastating clinical pathological syndrome resulting from the loss of intestinal length due to disease or surgical resection, generally defined as a residual small intestinal length of 200 cm or less. 1

Definition and Diagnostic Criteria

  • SBS occurs when, after surgery or congenitally, a patient is left with insufficient functional small intestine, leading to malabsorption of nutrients, fluids, and electrolytes 1
  • While 200 cm is the generally accepted threshold, some reports suggest that a residual length of 150 cm or less may be more appropriate for diagnosis 1
  • The measurement of bowel length should be taken from the duodenojejunal flexure to the ileocecal junction, the site of any small bowel-colon anastomosis, or to the end-ostomy 1
  • Normal human small intestinal length varies from approximately 275 cm to 850 cm, and tends to be shorter in women 1

Anatomical Classification

SBS patients can be classified into three distinct anatomical groups:

  • Group 1: End-jejunostomy - patients with jejunoileal resection, colectomy, and formation of a stoma (most severe phenotype) 1
  • Group 2: Jejunocolonic anastomosis - patients with jejunoileal resection and jejunocolic anastomosis (partial colon) 1
  • Group 3: Jejuno-ileo-colic anastomosis - patients with jejunal resection but intact ileum and colon (most favorable phenotype) 1

Clinical Manifestations

  • General consequences include diarrhea, dehydration, electrolyte abnormalities, and weight loss due to loss of digestive and absorptive surface area 1, 2
  • Specific consequences relate to the regions of gastrointestinal tract missing:
    • Terminal ileum loss: vitamin B12 deficiency, bile acid-induced diarrhea 1
    • Colon loss: increased fluid and electrolyte losses 1
  • Patients at greatest nutritional risk generally have:
    • Duodenostomy or jejunoileal anastomosis with ≤35 cm of residual small intestine 1
    • Jejunocolic or ileocolic anastomosis with ≤60 cm of residual small intestine 1
    • End jejunostomy with ≤115 cm of residual small intestine 1

Relationship to Intestinal Failure

  • While SBS and intestinal failure (IF) are often used interchangeably, they represent distinct concepts 1
  • IF is defined as the reduction of gut function below the minimum necessary for absorption of macronutrients or water and electrolytes, requiring intravenous supplementation 1
  • SBS is the most common cause of IF, but IF can also result from other disorders like chronic intestinal pseudo-obstruction 1
  • IF severity is classified as:
    • Severe: requiring parenteral nutrition
    • Moderate: requiring enteral nutrition
    • Mild: requiring oral nutritional supplements 1

Prognostic Factors

  • The remaining anatomy and length of bowel after intestinal resection have important prognostic implications 3
  • Presence of the ileocecal valve and functional colon significantly improves prognosis 1, 4
  • Patients with jejunum-colon anatomy may need parenteral nutrition if less than 50 cm small intestine remains 1
  • Patients with jejunostomy may need:
    • Parenteral saline if less than 100 cm of jejunum remains
    • Parenteral nutrition and saline if less than 75 cm remains 1
  • The probability of weaning from parenteral nutrition becomes less than 10% if not achieved within the first 2 years following the last bowel resection 5

Clinical Complications

  • Fluid and electrolyte imbalances, particularly hypomagnesemia 1, 4
  • Malnutrition and specific nutrient deficiencies (vitamins, minerals, trace elements) 2
  • D-lactic acidosis from bacterial fermentation of unabsorbed carbohydrates 4
  • Renal oxalate stones (25% risk in patients with preserved colon) 4
  • Gallstone formation (45% in short bowel patients) 4
  • Small intestinal bacterial overgrowth, especially when the ileocecal valve has been resected 4, 2

SBS represents a spectrum of disease severity requiring individualized management by an experienced multidisciplinary team, with treatment approaches varying based on the remaining bowel anatomy, length, and function 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Short bowel syndrome: Complications and management.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2023

Research

Short Bowel Syndrome in Adults.

The American journal of gastroenterology, 2022

Guideline

Management of Short Bowel Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Management of Short Bowel Syndrome in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.